找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: International Conference on Artificial Intelligence and Sustainable Engineering; Select Proceedings o Goutam Sanyal,Carlos M. Travieso-Gonz

[復(fù)制鏈接]
樓主: invigorating
11#
發(fā)表于 2025-3-23 10:46:10 | 只看該作者
Nitin Rastogi,Aravendra Kumar Sharmamay provide accurate predictions of the dose-effect relationships by advancing the understanding of target engagement as well as exposure response and therefore has the potential to improve the decision making regarding the optimal dose and schedules as well as risk-benefit assessments for later sta
12#
發(fā)表于 2025-3-23 14:15:25 | 只看該作者
Sadhana Singh,Aaryan Gupta,R. S. Pavithrucosal, and local. Furthermore, a targeted and individualized approach for drug monitoring was developed that takes into account individual patient variability through careful gathering of pharmacokinetic and pharmacodynamic data: therapeutic drug monitoring, allowing to really individualize patient
13#
發(fā)表于 2025-3-23 20:27:58 | 只看該作者
Anita Shrotriya,Akhilesh Kumar Sharma,Jyoti Grover stores by reserpine and after treatment with phenothiazines and other antipsychotic drugs blocking dopamine receptors (Vernier 1964; Marsden et al. 1975; Duvoisin 1976; Hornykiewicz 1975; Miller and Hiley 1975). The pathology of Parkinson’s disease is typified by the presence of cytoplasmic inclusi
14#
發(fā)表于 2025-3-24 01:28:36 | 只看該作者
15#
發(fā)表于 2025-3-24 05:52:39 | 只看該作者
16#
發(fā)表于 2025-3-24 09:43:35 | 只看該作者
17#
發(fā)表于 2025-3-24 11:44:00 | 只看該作者
with human studies on tolerability and therapeutic effects. Special studies according to various populations and different therapeutic indications are necessary. These items are covered in the third volume: ?Me978-3-540-89891-7
18#
發(fā)表于 2025-3-24 15:44:04 | 只看該作者
Ankita Vaish,Ruchi Agarwal,Manoj Kumarwith human studies on tolerability and therapeutic effects. Special studies according to various populations and different therapeutic indications are necessary. These items are covered in the third volume: ?Me978-3-540-89891-7
19#
發(fā)表于 2025-3-24 20:34:57 | 只看該作者
20#
發(fā)表于 2025-3-25 00:53:20 | 只看該作者
D. P. Yadavefore adopted, involving the following changes: .-????????? Parallel instead of sequential involvement of the various disciplines (multidimensional compound optimization)..-????????? The term "Safety Pharmacolo978-3-642-25240-2
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 13:29
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
辽阳县| 临沭县| 秦皇岛市| 方正县| 巴塘县| 庄浪县| 韩城市| 桐城市| 麻栗坡县| 云安县| 卢湾区| 花莲市| 弥勒县| 宝丰县| 嘉荫县| 深圳市| 宁河县| 阳谷县| 改则县| 乌拉特后旗| 邵阳市| 扎囊县| 安阳市| 邵阳县| 津市市| 菏泽市| 双流县| 洛扎县| 罗江县| 河池市| 色达县| 四川省| 宁乡县| 光山县| 保山市| 定边县| 铜川市| 永城市| 沐川县| 竹山县| 昌宁县|